Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPATASERTIB vs IPTACOPAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPATASERTIB vs IPTACOPAN: Safety Overview

Metric IPATASERTIB IPTACOPAN
Total FAERS Reports 125 468
Deaths Reported 20 23
Death Rate 16.0% 4.9%
Hospitalizations 95 88
Average Patient Age 61.7 yrs 48.8 yrs
% Female Patients 57.0% 53.4%
FDA Approval Date N/A Dec 5, 2023
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription